Prostaglandin D2 and adenosine as endogenous somnogens

Sleep and Biological Rhythms

Volumn 9, Issue SUPPL. 1, 2011, Pages 10-17

  Urade, Yoshihiro ^a  

^a OSAKA BIOSCIENCE INSTITUTE   (Japan)

Author keywords

Adenosine; Adenosine A1 receptor; Adenosine A2A receptor; DP1 receptor; Gene knockout mice; Prostaglandin D synthase; Prostaglandin D2

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; CAFFEINE; LIPOCALIN; ONO 4127; OREXIN; PROSTAGLANDIN D SYNTHASE; PROSTAGLANDIN D2; PROSTAGLANDIN RECEPTOR; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; UNCLASSIFIED DRUG; ADENOSINE A2A RECEPTOR; THROMBOXANE A2;

CEREBROSPINAL FLUID; CHOLINERGIC SYSTEM; CHOROID PLEXUS; FOREBRAIN; GABAERGIC SYSTEM; HUMAN; NONHUMAN; OLIGODENDROGLIA; POSTERIOR HYPOTHALAMUS; PREOPTIC AREA; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; PROSTAGLANDIN RELEASE; RECEPTOR BINDING; RECEPTOR BLOCKING; REM SLEEP; REVIEW; SLEEP DISORDER; SLEEP INDUCTION; SLEEP WAKING CYCLE; ANIMAL EXPERIMENT; ARACHNOID; BASAL FOREBRAIN; CATAPLEXY; CEREBROSPINAL FLUID ANALYSIS; DAYTIME SOMNOLENCE; HYPOTHALAMUS; INSOMNIA; LEPTOMENINX; MOUSE; MULTICENTER STUDY; PROSTAGLANDIN SYNTHESIS; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SLEEP AROUSAL DISORDER; X RAY CRYSTALLOGRAPHY;

EID: 79951985021     PISSN: 14469235     EISSN: 14798425     Source Type: Journal    
DOI: 10.1111/j.1479-8425.2010.00470.x     Document Type: Review

References (36)

1. 2 induces sleep when microinjected into the preoptic area of conscious rats. Biochem. Biophys. Res. Commun. 1982; 109: 576-82.
2. 2 in patients with systemic mastocytosis. N. Engl. J. Med. 1980; 303: 1400-4.
3. 2 is selectively elevated in cerebrospinal fluid of advanced sleeping sickness patients. Trans. R. Soc. Trop. Med. Hyg. 1990; 84: 795-9.
4. 2 may predict the occurrence of sleep or wakefulness as assessed by parallel EEG and microdialysis in the rat. Brain Res. 1995; 689: 239-44.
5. 2. FASEB J. 1991; 5: 2575-81.
6. 2 and adenosine in sleep regulation: experimental evidence from pharmacological approaches to gene-knockout mice. Future Neurol. 2010; 5: 363-76.
7. Huang ZL, Urade Y, Hayaishi O. Prostaglandins and adenosine in the regulation of sleep and wakefulness. Curr. Opin. Pharmacol. 2007; 7: 33-8.
8. Hayaishi O, Urade Y. Prostaglandins and the Regulation of Sleep and Wakefulness. Cambridge University Press: Cambridge, 2008.
9. Urade Y, Eguchi N. Lipocalin-type and hematopoietic prostaglandin D synthases as a novel example of functional convergence. Prostaglandins Other Lipid Mediat. 2002; 68-69: 375-82.
10. Urade Y, Hayaishi O. Prostaglandin D synthase: structure and function. Vitam. Horm. 2000; 58: 89-120.
11. Urade Y, Eguchi N, Hayaishi O. Lipocalin-Type Prostaglandin D Synthase as an Enzymic Lipocalin. Landes Bioscience / Eurekah.com: Georgetown, TX, 2006.
12. Shimamoto S, Yoshida S, Inui T etal. NMR solution structure of lipocalin-type prostaglandin D synthase: evidence for partial overlapping of catalytic pocket and retinoic acid-binding pocket within the central cavity. J. Biol. Chem. 2007; 282: 31373-9.
13. Kumasaka T, Aritake K, Ago H etal. Structural basis of the catalytic mechanism operating in open-closed conformers of lipocalin type prostaglandin D synthase. J. Biol. Chem. 2009; 284: 22344-52.
14. Urade Y, Kitahama K, Ohishi H, Kaneko T, Mizuno N, Hayaishi O. Dominant expression of mRNA for prostaglandin D synthase in leptomeninges, choroid plexus, and oligodendrocytes of the adult rat brain. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 9070-4.
15. Beuckmann CT, Lazarus M, Gerashchenko D etal. Cellular localization of lipocalin-type prostaglandin D synthase (beta-trace) in the central nervous system of the adult rat. J. Comp. Neurol. 2000; 428: 62-78.
16. Hirata M, Kakizuka A, Aizawa M, Ushikubi F, Narumiya S. Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene. Proc. Natl. Acad. Sci. U. S. A. 1994; 91: 11192-6.
17. 2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J. Exp. Med. 2001; 193: 255-61.
18. Mizoguchi A, Eguchi N, Kimura K etal. Dominant localization of prostaglandin D receptors on arachnoid trabecular cells in mouse basal forebrain and their involvement in the regulation of non-rapid eye movement sleep. Proc. Natl. Acad. Sci. U. S. A. 2001; 98: 11674-9.
19. 2 involved in regulation of physiological sleep. Proc. Natl. Acad. Sci. U. S. A. 2006; 103: 17949-54.
20. Basheer R, Strecker RE, Thakkar MM, McCarley RW. Adenosine and sleep-wake regulation. Prog. Neurobiol. 2004; 73: 379-96.
21. Porkka-Heiskanen T, Alanko L, Kalinchuk A, Stenberg D. Adenosine and sleep. Sleep Med. Rev. 2002; 6: 321-32.
22. Radulovacki M. Adenosine sleep theory: how I postulated it. Neurol. Res. 2005; 27: 137-8.
23. 1 receptors and promotes non-rapid eye movement sleep. Proc. Natl. Acad. Sci. U. S. A. 2008; 105: 19992-7.
24. 2A receptor-deficient mice. Neurology 2003; 61: S94-96.
25. 2. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: 7754-9.
26. 2a agonist increases sleep and induces Fos in ventrolateral preoptic neurons. Neuroscience 2001; 107: 653-63.
27. 2A receptors in the ventrolateral preoptic nucleus. Neuroscience 2005; 134: 1377-90.
28. Sherin JE, Shiromani PJ, McCarley RW, Saper CB. Activation of ventrolateral preoptic neurons during sleep. Science 1996; 271: 216-19.
29. Hong ZY, Huang ZL, Qu WM, Eguchi N, Urade Y, Hayaishi O. An adenosine A receptor agonist induces sleep by increasing GABA release in the tuberomammillary nucleus to inhibit histaminergic systems in rats. J. Neurochem. 2005; 92: 1542-9.
30. Saper CB, Scammell TE, Lu J. Hypothalamic regulation of sleep and circadian rhythms. Nature 2005; 437: 1257-63.
31. 1, receptors mediate the arousal effect of caffeine. Nat. Neurosci. 2005; 8: 858-9.
32. Irikura D, Aritake K, Nagata N etal. Biochemical, functional, and pharmacological characterization of AT-56, an orally active and selective inhibitor of lipocalin-type prostaglandin D synthase. J. Biol. Chem. 2009; 284: 7623-30.
33. Jordan W, Tumani H, Cohrs S etal. Prostaglandin D synthase (beta-trace) in healthy human sleep. Sleep 2004; 27: 867-74.
34. Jordan W, Tumani H, Cohrs S etal. Narcolepsy increased L-PGDS (beta-trace) levels correlate with excessive daytime sleepiness but not with cataplexy. J. Neurol. 2005; 252: 1372-8.
35. Bassetti CL, Hersberger M, Baumann CR. CSF prostaglandin D synthase is reduced in excessive daytime sleepiness. J. Neurol. 2006; 253: 1030-3.
36. Retey JV, Adam M, Honegger E etal. A functional genetic variation of adenosine deaminase affects the duration and intensity of deep sleep in humans. Proc. Natl. Acad. Sci. U. S. A. 2005; 102: 15676-81.